Mahamaya Lifesciences: Monitoring Agency Report Submission

Mahamaya Lifesciences Ltd submitted a Monitoring Agency Report for the half year ended March 31, 2026, as required under Regulation 32 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report, issued by Infomerics Valuation and Rating Limited, covers the period from November 18, 2025, to March 31, 2026, and pertains to the utilization of proceeds raised through the company's Initial Public Offer (IPO). The company has also approved rescheduling of utilization of the unutilised IPO proceeds in subsequent fiscal years up to March 31, 2028.